文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

每小时净超滤率对接受连续性肾脏替代治疗的危重患者死亡率影响的中介因素

Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论早期净超滤率大于1.75 mL/kg/hr与危重患者住院死亡率独立相关,该效应为直接效应,未经液体平衡、低血压、血管升压药使用、低钾或低磷血症中介。

该回顾性观察研究纳入澳大利亚墨尔本Austin医院混合内外科ICU中接受连续性肾脏替代治疗且在ICU入住14天内开始治疗、存活超过48小时的347例危重患者,探讨早期(前48小时)净超滤率与住院死亡率的关系是否由液体平衡、血流动力学不稳定或低钾/低磷血症中介。调整混杂因素后,净超滤率大于1.75 mL/kg/hr相比小于1.01 mL/kg/hr与显著更高的死亡率相关(调整OR 1.15;95%CI 1.03-1.29;P=0.011)。单变量中介分析未发现血压、血管升压药治疗或钾水平有因果中介通路,液体平衡(平均因果中介效应0.95;95%CI 0.89-1.00;P=0.060)和低磷血症测量百分比(平均因果中介效应0.96;95%CI 0.92-1.00;P=0.055)可能中介,但多中介分析无显著效应;高净超滤率的平均直接效应为1.24(95%CI 1.11-1.40;P<0.001)。

要点

  • 早期净超滤率大于1.75 mL/kg/hr相比小于1.01 mL/kg/hr与住院死亡率显著升高独立相关(调整OR 1.15;95%CI 1.03-1.29;P=0.011)。
  • 该效应为直接效应(平均直接效应1.24;95%CI 1.11-1.40;P<0.001),未经液体平衡、低血压、血管升压药使用、低钾或低磷血症中介。
  • 单变量中介分析中液体平衡(平均因果中介效应0.95;95%CI 0.89-1.00;P=0.060)和低磷血症测量百分比(平均因果中介效应0.96;95%CI 0.92-1.00;P=0.055)可能中介,但多中介分析无显著效应。
  • 研究为回顾性观察设计,纳入347例接受连续性肾脏替代治疗的危重患者,中位年龄64岁(IQR 53-71岁),APACHE III评分73(IQR 54-90)。

适用人群与场景

  • 澳大利亚墨尔本Austin医院混合内外科ICU中接受连续性肾脏替代治疗的危重患者
  • 纳入标准:ICU入住14天内开始连续性肾脏替代治疗且存活超过48小时

诊断标准与关键阈值

  • 早期净超滤率分组阈值:小于1.01 mL/kg/hr为参照组,大于1.75 mL/kg/hr为高净超滤率组

研究设计与关键结果

  • 研究类型:回顾性观察研究;样本量347例;单中心(澳大利亚墨尔本Austin医院混合内外科ICU)
  • 人群特征:中位年龄64岁(IQR 53-71岁),APACHE III评分73(IQR 54-90)
  • 主要终点(住院死亡率):调整混杂因素后,净超滤率大于1.75 mL/kg/hr相比小于1.01 mL/kg/hr与显著更高死亡率相关(调整OR 1.15;95%CI 1.03-1.29;P=0.011)
  • 单变量中介分析:血压、血管升压药治疗或钾水平无因果中介通路提示;液体平衡平均因果中介效应0.95(95%CI 0.89-1.00;P=0.060),低磷血症测量百分比平均因果中介效应0.96(95%CI 0.92-1.00;P=0.055),可能中介
  • 多中介分析:液体平衡和低磷血症测量百分比无显著效应
  • 高净超滤率的平均直接效应:1.24(95%CI 1.11-1.40;P<0.001)

证据类型、等级与局限

  • 证据类型:回顾性观察研究
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文结论:早期净超滤率大于1.75 mL/kg/hr与住院死亡率独立相关,其效应为直接效应,未经液体平衡、低血压、血管升压药使用、低钾或低磷血症中介。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: During continuous renal replacement therapy, a high net ultrafiltration rate has been associated with increased mortality. However, it is unknown what might mediate its putative effect on mortality. In this study, we investigated whether the relationship between early (first 48 hr) net ultrafiltration and mortality is mediated by fluid balance, hemodynamic instability, or low potassium or phosphate blood levels using mediation analysis and the primary outcome was hospital mortality.

DESIGN: Retrospective, observational study.

SETTING: Mixed medical and surgical ICUs at Austin hospital, Melbourne, Australia.

PATIENTS: Critically ill patients treated with continuous renal replacement therapy within 14 days of ICU admission who survived greater than 48 hours.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We studied 347 patients (median [interquartile range] age: 64 yr [53-71 yr] and Acute Physiology and Chronic Health Evaluation III score: 73 (54-90)]. After adjustment for confounders, compared with a net ultrafiltration less than 1.01 mL/kg/hr, a net ultrafiltration rate greater than 1.75 mL/kg/hr was associated with significantly greater mortality (adjusted odds ratio, 1.15; 95% CI, 1.03-1.29; p = 0.011). Adjusted univariable mediation analysis found no suggestion of a causal mediation pathway for this effect by blood pressure, vasopressor therapy, or potassium levels, but identified a possible mediation effect for fluid balance (average causal mediation effect, 0.95; 95% CI, 0.89-1.00; p = 0.060) and percentage of phosphate measurements with hypophosphatemia (average causal mediation effect, 0.96; 95% CI, 0.92-1.00; p = 0.055). However, on multiple mediator analyses, these two variables showed no significant effect. In contrast, a high net ultrafiltration rate had an average direct effect of 1.24 (95% CI, 1.11-1.40; p < 0.001).

CONCLUSIONS: An early net ultrafiltration greater than 1.75 mL/kg/hr was independently associated with increased hospital mortality. Its putative effect on mortality was direct and not mediated by a causal pathway that included fluid balance, low blood pressure, vasopressor use, hypokalemia, or hypophosphatemia.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Naorungroj T, Neto AS, Zwakman-Hessels L, et al. Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. Crit Care Med. 2020. PMID: 32885938. doi:10.1097/CCM.0000000000004508

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。